Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

FDA Grants Orphan Drug Status to Erwinaze for Treatment of Acute Lymphoblastic Leukemia

November 18th 2011

The FDA granted orphan drug approval to Erwinaze (asparaginase Erwinia chrysanthemi) to treat acute lymphoblastic leukemia (ALL).

Dr. Berenson Discusses the Carfilzomib Toxicity Profile

November 18th 2011

Dr. James Berenson from the Institute for Myeloma & Bone Cancer Research Discusses the Carfilzomib Toxicity Profile

Ruxolitinib Gains FDA Approval for Bone Marrow Disease

November 17th 2011

The FDA approved ruxolitinib (Jakafi) as the first drug to specifically treat patients with myelofibrosis, a bone marrow disease.

Management of Adult ALL Refined

November 16th 2011

Outcomes in the treatment of acute lymphoblastic leukemia (ALL) differ in children and adults, with pediatric patients (including adolescents and young adults) having much higher cure rates than adults.

Evidence for Allogeneic Versus Autologous Stem Cell Transplant in Hematologic Malignancies

November 15th 2011

William I. Bensinger, MD, tackles the complex subject of the role of hematopoietic stem cell transplantation (HSCT), including when to transplant and whether to use allogeneic versus autologous transplant.

Novel Drugs and Combinations Promise to Improve Outcomes for Patients With Myeloma

November 14th 2011

Current treatments revolutionized multiple myeloma but combinations and novel approaches in development promise to make even greater strides in treating this disease.

Dr. Diehl Compares US and EU Hodgkin Lymphoma Staging

November 14th 2011

Dr. Volker Diehl from the University of Cologne, Germany, Compares US and EU Hodgkin Lymphoma Staging

Dr. Berenson on Carfilzomib for Multiple Myeloma

November 10th 2011

Dr. James Berenson from the Institute for Myeloma and Bone Cancer Research Discusses the Proteasome Inhibitor Carfilzomib

Dr. Diehl on the Unique Nature of Hodgkin's Lymphoma

November 8th 2011

Dr. Volker Diehl from the University of Cologne, Germany on the Unique Nature of Hodgkin's Lymphoma

Loan Repayment Programs for Oncology/Hematology Fellows

October 31st 2011

It’s no surprise that you acquire significant debt during your medical training. Here are some ways to get those loans paid off.

The Biology of Burnout

October 31st 2011

Burnout is a recurring problem for overworked oncologists and hematologists. This article includes ideas to keep you healthy, engaged, and empathic.

Caring for Our Uninsured Patients

October 31st 2011

Ideally, all patients should receive the same oncology care, regardless of their ability to pay. The reality is often different, as this fellow can attest.

How to Perform the Perfect Bone Marrow Biopsy

October 31st 2011

Obtaining a high-quality bone marrow aspirate and biopsy is very important for the patient—and for you. Following these general guidelines will help you do this successfully.

Public Speaking Tips for Fellows

October 31st 2011

All fellows will at some point in their careers be required to speak in public. This article provides a number of tips to make that task easier.

Progress Made, but More Work Lies Ahead in CLL and CRC Treatment

October 31st 2011

A look at the benefits of the chemoimmunotherapy rituximab for CLL and a look at the treatments and advances made in treating metastatic CRC.

Dr. Mistry on Gaucher Disease Entering a New Era

October 27th 2011

Dr. Pramod Mistry from Yale University School of Medicine on Gaucher Disease Entering a New Era

Dr. Grabowski Explains the Effects of Enzyme Therapy

October 24th 2011

Dr. Gregory A. Grabowski from Cincinnati Children's Hospital Medical Center Explains the Effects of Enzyme Therapy

Dr. Vivaldi on the Gaucher Disease Transformation

October 24th 2011

Dr. Rogerio Vivaldi the President of Genzyme Corporation on the Transformation of Gaucher Disease

Dr. Mistry Explains the History of Gaucher Disease

October 21st 2011

Dr. Pramod Mistry from the Yale University School of Medicine Explains the History of Gaucher Disease

Dr. Moscicki on His Experience With Lysosomal Diseases

October 21st 2011

Dr. Richard Moscicki from Chief Medical Officer, Genzyme Corporation, on His Experience With Lysosomal Diseases

NEXT PAGE
PREVIOUS PAGE